Cai Yingying, Liu Yuting, Culhane Kelly J, DeVree Brian T, Yang Yang, Sunahara Roger K, Yan Elsa C Y
Department of Chemistry, Yale University, New Haven, Connecticut, United States of America.
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, United States of America.
PLoS One. 2017 Jun 13;12(6):e0179568. doi: 10.1371/journal.pone.0179568. eCollection 2017.
Family B G protein-coupled receptors (GPCRs) play vital roles in hormone-regulated homeostasis. They are drug targets for metabolic diseases, including type 2 diabetes and osteoporosis. Despite their importance, the signaling mechanisms for family B GPCRs at the molecular level remain largely unexplored due to the challenges in purification of functional receptors in sufficient amount for biophysical characterization. Here, we purified the family B GPCR human glucagon-like peptide-1 (GLP-1) receptor (GLP1R), whose agonists, e.g. exendin-4, are used for the treatment of type 2 diabetes mellitus. The receptor was expressed in HEK293S GnTl- cells using our recently developed protocol. The protocol incorporates the receptor into the native-like lipid environment of reconstituted high density lipoprotein (rHDL) particles, also known as nanodiscs, immediately after the membrane solubilization step followed by chromatographic purification, minimizing detergent contact with the target receptor to reduce denaturation and prolonging stabilization of receptor in lipid bilayers without extra steps of reconstitution. This method yielded purified GLP1R in nanodiscs that could bind to GLP-1 and exendin-4 and activate Gs protein. This nanodisc purification method can potentially be a general strategy to routinely obtain purified family B GPCRs in the 10s of microgram amounts useful for spectroscopic analysis of receptor functions and activation mechanisms.
B族G蛋白偶联受体(GPCRs)在激素调节的体内平衡中发挥着至关重要的作用。它们是包括2型糖尿病和骨质疏松症在内的代谢性疾病的药物靶点。尽管它们很重要,但由于难以纯化出足够量的功能性受体用于生物物理特性分析,B族G蛋白偶联受体在分子水平上的信号传导机制在很大程度上仍未得到探索。在此,我们纯化了B族G蛋白偶联受体人胰高血糖素样肽-1(GLP-1)受体(GLP1R),其激动剂,如艾塞那肽-4,用于治疗2型糖尿病。该受体使用我们最近开发的方案在HEK293S GnTl-细胞中表达。该方案在膜溶解步骤后立即将受体整合到重组高密度脂蛋白(rHDL)颗粒(也称为纳米圆盘)的天然脂质环境中,随后进行色谱纯化,尽量减少去污剂与目标受体的接触以减少变性,并在脂质双层中延长受体的稳定性,而无需额外的重组步骤。这种方法产生了存在于纳米圆盘中的纯化GLP1R,其能够与GLP-1和艾塞那肽-4结合并激活Gs蛋白。这种纳米圆盘纯化方法可能是一种常规策略,可用于常规获得10微克量级的纯化B族G蛋白偶联受体,这对于受体功能和激活机制的光谱分析很有用。